title: Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users.
abstract: OBJECTIVE
  The long-term effects of the use of 3,4-methylenedioxymethamphetamine (MDMA, or Ecstasy) in humans are controversial and unclear. The authors' goal was to assess the contribution of a functional polymorphism in the gene encoding serotonin transporter to changes in emotional processing following chronic Ecstasy use.
  
  
  METHODS
  They investigated Beck Depression Inventory scores and performance on the Affective Go/No-Go test, a computerized neuropsychological test sensitive to emotional processing, in Ecstasy users and comparison subjects, stratifying the results by serotonin transporter genotype.
  
  
  RESULTS
  Ecstasy use was associated with higher Beck Depression Inventory score and abnormalities in the Affective Go/No-Go test in individuals with the ss and ls genotype but not those with the ll genotype.
  
  
  CONCLUSIONS
  Ecstasy users carrying the s allele, but not comparison subjects carrying the s allele, showed abnormal emotional processing. On the basis of a comparison with acute tryptophan depletion, the authors hypothesize that chronic Ecstasy use may cause long-term changes to the serotonin system, and that Ecstasy users carrying the s allele may be at particular risk for emotional dysfunction.
authors.affiliation: Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrooke,s Hospital, Cambridge CB2 2QQ, UK. roiserj@mail.nih.gov
authors.forename: Jonathan P
authors.initials: JP
authors.lastname: Roiser
authors.forename: Lynnette J
authors.initials: LJ
authors.lastname: Cook
authors.forename: Jason D
authors.initials: JD
authors.lastname: Cooper
authors.forename: David C
authors.initials: DC
authors.lastname: Rubinsztein
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Sahakian
mesh_terms: D000328:Adult; D000342:Affective Symptoms / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology; D003866:Depressive Disorder / Q000175:diagnosis / Q000235:genetics; D017831:Diagnosis, Dual (Psychiatry); D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000502:physiology; D026901:Membrane Transport Proteins / Q000235:genetics* / Q000502:physiology; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects*; D009419:Nerve Tissue Proteins / Q000235:genetics* / Q000502:physiology; D009483:Neuropsychological Tests; D010555:Personality Inventory; D011110:Polymorphism, Genetic / Q000235:genetics / Q000502:physiology; D050486:Serotonin Plasma Membrane Transport Proteins; D019966:Substance-Related Disorders / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology; D014364:Tryptophan / Q000172:deficiency
chemical_list: D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D014364:Tryptophan; D018817:N-Methyl-3,4-methylenedioxyamphetamine
references.citation: Psychopharmacology (Berl). 2001 Mar;154(3):319-26
references.pmid: 11351939
references.citation: J Psychopharmacol. 2002 Mar;16(1):103
references.pmid: 11949766
references.citation: Pharmacol Rev. 2003 Sep;55(3):463-508
references.pmid: 12869661
references.citation: Neuropsychopharmacology. 1998 Jul;19(1):26-35
references.pmid: 9608574
references.citation: Neuroscience. 2002;110(1):41-8
references.pmid: 11882371
references.citation: J Psychopharmacol. 2001 Sep;15(3):181-6
references.pmid: 11565625
references.citation: Psychopharmacology (Berl). 2002 Aug;163(1):42-53
references.pmid: 12185399
references.citation: Psychopharmacology (Berl). 2004 Jan;171(3):286-97
references.pmid: 12955284
references.citation: Arch Gen Psychiatry. 2002 Jul;59(7):613-20
references.pmid: 12090814
references.citation: Arch Gen Psychiatry. 1961 Jun;4:561-71
references.pmid: 13688369
references.citation: Mol Psychiatry. 1998 Nov;3(6):508-11
references.pmid: 9857976
references.citation: Arch Gen Psychiatry. 2002 Jul;59(7):597-604
references.pmid: 12090812
references.citation: Hum Psychopharmacol. 2001 Dec;16(8):641-645
references.pmid: 12404545
references.citation: Am J Med Genet. 1998 Feb 7;81(1):58-63
references.pmid: 9514589
references.citation: Psychol Med. 1999 Nov;29(6):1307-21
references.pmid: 10616937
references.citation: Neurology. 2000 Jul 25;55(2):294-6
references.pmid: 10908909
references.citation: Lancet. 2001 Dec 1;358(9296):1864-9
references.pmid: 11741626
references.citation: Science. 1996 Nov 29;274(5292):1527-31
references.pmid: 8929413